Adlai Nortye (ANL) Common Equity (2022 - 2025)
Adlai Nortye's (ANL) quarterly Common Equity came in at -$8.3 million in Q4 2025, down 132.65% year-on-year from $25.5 million in Q4 2024, and down 205.06% on a QoQ basis from $7.9 million in Q2 2025.
Adlai Nortye (ANL) Common Equity (2022 - 2025) Analysis & Trends
Adlai Nortye (ANL) has 4 years of Common Equity data on file, last reported at -$8.3 million in Q4 2025.
- On a quarterly basis, Common Equity fell 132.65% year-over-year to -$8.3 million in Q4 2025; TTM through Dec 2025 was -$8.3 million, a 132.65% decrease from a year earlier, with the FY2025 full-year figure at -$8.3 million, down 132.65% from the prior year.
- Common Equity for Q4 2025 stood at -$8.3 million, down from $7.9 million in the prior quarter.
- Over the last five years, Common Equity for ANL reached as high as $75.0 million in Q4 2023 and fell as low as -$241.3 million in Q4 2022.
- Historically, Common Equity has averaged -$24.3 million across 4 years, with a median of $1.8 million in 2024.
- On a YoY basis, Common Equity climbed as much as 281.8% in 2025 and fell as far as 132.65% in 2025.
- Year by year, Common Equity stood at -$241.3 million in 2022, then jumped by 131.1% to $75.0 million in 2023, then plunged by 66.04% to $25.5 million in 2024, then slumped by 132.65% to -$8.3 million in 2025.
- Per Business Quant data, the three most recent Common Equity figures were -$8.3 million in Q4 2025, $7.9 million in Q2 2025, and $25.5 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 251.12 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | -98.34 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 14.38 Mn |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 4.76 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 19.36 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 31.42 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | 795.79 Mn |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 1.50 Bn |
| 10 | Adlai Nortye | 1.16 Bn | 1.15 Bn | - | -8.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -8.32 Mn |
| Jun 30, 2025 | 7.92 Mn |
| Dec 31, 2024 | 25.49 Mn |
| Jun 30, 2024 | -4.36 Mn |
| Dec 31, 2023 | 75.05 Mn |
| Dec 31, 2022 | -241.29 Mn |